据向SEC提交的文件显示,FDA建议REIN THERAPEUTICS INC提交完整回应函,以处理修订后的研究报告和相关证明材料。
据向SEC提交的文件显示,FDA建议REIN THERAPEUTICS INC提交完整回应函,以处理修订后的研究报告和相关证明材料。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.